Premodifier: general corporate
Head noun: purpose

Same concepts

Broader concepts

labelprovenanceconfidence
capital expenditureisap:645382160.686624
purposeisap:4338060880.604074

Narrower concepts

labelprovenanceconfidence
share repurchaseisap:2189442980.870334
future acquisitionisap:1385933580.869387
possible acquisitionisap:1385933550.868729
clinical trialisap:2252310370.863075
capital expenditureisap:1381482960.862571
capital needisap:16889000.854225
common stockisap:2234971150.853857
administrative expenseisap:4345701810.852151
capital requirementisap:1399156570.832826
product developmentisap:1387080610.830977
capital purposeisap:4338061110.829422
other purposeisap:4338061930.823611
debt repaymentisap:285612270.818298
potential acquisitionisap:1385933540.807361
growth initiativeisap:2201900950.806525
potential future development programisap:4356230870.805979
strategic growth initiativeisap:2201900990.805686
additional acquisitionisap:1385934100.804252
potential future acquisitionisap:1385933590.801520
ongoing working capitalisap:4349554540.799513
acquisition activityisap:3442101180.798244
strategic acquisitionisap:1385933730.797096
vessel acquisitionisap:1385933660.795712
game developmentisap:1387080950.794113
complementary businessisap:3435420730.791088
strategic initiativeisap:2201900970.789542
business acquisitionisap:1385933740.789333
capital expenseisap:4345701870.786593
capital investmentisap:2191092550.782948
growth capitalisap:4349554520.782275
stock repurchaseisap:2189443000.780978
debt reductionisap:254986940.780350
outstanding debtisap:50612390.773452
development projectisap:4323364310.772977
development activityisap:3442100890.771312
marketing expenseisap:4345702000.769801
short-term debtisap:50612460.769527
ongoing researchisap:3407655260.769255
common shareisap:2240012620.765202
marketing activityisap:3442100930.763930
operating expenseisap:4345701980.762966
working capitalisap:4349554410.760791
dividend paymentisap:4288247570.760304
other product candidateisap:240606510.757993
growth strategyisap:3416599260.756162
strategic transactionisap:1398348450.751499
employee benefit planisap:115538650.751275
organic growthisap:4405484930.750707
early-stage researchisap:3407655790.747909
balance sheetisap:2233138440.746439
marketing effortisap:4458916220.737550
business strategyisap:3416599250.735135
fund working capitalisap:4349554380.733437
other researchisap:3407655440.720382
inventory purchaseisap:3411325610.710044
repayment of commercial paperisap:285612290.705298
financing for work capitalisap:244590860.693419
funding of capital expenditureisap:4299389210.690750
acquisitionisap:1385933530.685274
pre-clinical studyisap:2303691240.677801
borrowing under the creditisap:255506250.669874
payment of principalisap:4288247760.666921
refinancing of debtisap:1382316120.661317
repayment of debtisap:285612260.661165
advancement of the company'isap:1379263020.656913
funding for work capitalisap:4299389440.656633
letter of creditisap:4446225570.656414
expansion of saleisap:265228310.653033
repayment of indebtednessisap:285612280.652406
development of product candidateisap:1387081040.650788
financing of acquisitionisap:244590880.650733
acquisition of landisap:1385934010.648804
researchisap:3407654980.647877
marketingisap:253182660.637121
expenseisap:4345701790.624405
reduction of debtisap:254987020.623476
productisap:4372509890.608325
retirement of debtisap:2199284270.605699
offering for work capitalisap:3453602810.601348
saleisap:33502690.601328
debtisap:50612330.588659
investment in subsidiaryisap:2191092710.586818
proceeds for work capitalisap:3426661730.583172
investmentisap:2191092500.582618
expenditureisap:1381483010.573103
developmentisap:1387080540.568882
capitalisap:4349554350.559676
purposeisap:4338061770.552795
distributionisap:1101586490.536214
repurchaseisap:2189442990.518121
expansionisap:265228200.516902
productionisap:2204039030.512229
indebtednessisap:1092237920.508612
activityisap:3442101020.506142
supportisap:4390113310.502077
mergerisap:4474389260.491989
interestisap:3443671950.488034
dividendisap:3438740660.487191
costisap:50391890.485166
portionisap:4294609080.471687
technologyisap:2174047500.466057
proceeds from offeringisap:3426661720.465605
serviceisap:4284028090.464773
growthisap:4405484920.460301
r&disap:2370308410.459558
operationisap:266952220.458699
maturityisap:3415748390.452424
futureisap:4403893320.450721
availability of financingisap:1093126460.441933
improvementisap:1402694290.438843
businessisap:3435420490.437282
customerisap:3416311380.380044
facilityisap:3471033210.377820
sisap:2998267440.363176
ratingisap:4428066590.197637